News

Use of Inclisiran in a Patient in Secondary Cardiovascular Prevention
Lowering LDL cholesterol (LDL-c) is one of the primary goals for reducing cardiovascular (CV) risk due to its proven mortality reduction. However, many patients with familial hypercholesterolemia or CV disease fail to reach target LDL-c levels even when given the maximum tolerated dose of conventional hypolipidemic treatment. For these patients, inclisiran—a small interfering RNA (siRNA) that lowers cholesterol—offers hope. In the following article, we present a model example of a patient after an acute coronary event for whom starting…

Cenobamate − A Case Study from Slovak Real Practice

Brigatinib in the Therapy of Pretreated Patients with Advanced ALK-Positive NSCLC

Addition of ixazomib to lenalidomide and dexamethasone in multiple myeloma − Data from real-world Czech practice

Consolidation therapy with brentuximab vedotin after autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma

Role of Transthyretin in the Development of Amyloidosis

3D Printing is Already Helping with Eye Prostheses: What Benefits Does the Innovation Offer Patients?

Bizarre Technological Innovations in Medicine − The Dark Side of Progress or the Reality of the Near Future?

Possible Uses of Desodrop in Therapy and Prevention of Ophthalmological Diseases

Factors Predicting Longer Survival in Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil
Conferences
News from the world of medicine
All conferences
Popular this week
- Shooting at the Faculty of Arts of Charles University and activation of the trauma plan at the First Surgical Clinic of the General Teaching Hospital
- BENIGN DERMATOSIS OF PENIS
- Does AI Evaluate Patients' Health More Accurately Than Doctors?
- Brain scans of patients with multiple sclerosis will be evaluated by AI
- New method promises personalized diagnostics and more effective diabetes treatment